Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹5,539 Cr
down ₹149 Cr vs Sep 2023
- Stocks held
- 30
- unchanged
- Top 10 weight
- 57.4%
- of the portfolio in its ten largest
- Cash & debt
- 3.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 19
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In October 2023 it disclosed 30 stocks worth ₹5,539 Cr, down ₹149 Cr from Sep 2023. Its largest positions were Sun Pharmaceutical Industries Limited (12.9%), Lupin Limited (7.7%), Cipla Limited (6.5%); the ten largest together made up 57.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.2% of its equity. Cash and debt stood at 3.9%. Compared with Sep 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
77%
Top-10 weight is higher than 77% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
59%
Holds more cash than 59% of peers
Holdings in October 2023
Download CSVEvery line the fund disclosed, with the change against Sep 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.88%
- Δ weight
- down 0.47 pts
- Value
- ₹714 Cr
- Δ value
- down ₹45.9 Cr
- Status
- Trimmed
- Weight
- 7.75%
- Δ weight
- down 0.09 pts
- Value
- ₹429 Cr
- Δ value
- down ₹16.4 Cr
- Status
- Trimmed
- Weight
- 6.50%
- Δ weight
- up 0.24 pts
- Value
- ₹360 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 5.33%
- Δ weight
- down 0.07 pts
- Value
- ₹295 Cr
- Δ value
- down ₹12.1 Cr
- Status
- Trimmed
- Weight
- 4.47%
- Δ weight
- up 0.73 pts
- Value
- ₹248 Cr
- Δ value
- up ₹35 Cr
- Status
- Added
- Weight
- 4.40%
- Δ weight
- up 0.24 pts
- Value
- ₹243 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 4.29%
- Δ weight
- down 0.35 pts
- Value
- ₹237 Cr
- Δ value
- down ₹26.4 Cr
- Status
- Trimmed
- Weight
- 4.19%
- Δ weight
- down 0.23 pts
- Value
- ₹232 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 3.92%
- Δ weight
- down 0.03 pts
- Value
- ₹217 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 3.83%
- Δ weight
- down 0.18 pts
- Value
- ₹212 Cr
- Δ value
- down ₹16.2 Cr
- Status
- Trimmed
- Weight
- 3.78%
- Δ weight
- down 0.12 pts
- Value
- ₹209 Cr
- Δ value
- down ₹12.6 Cr
- Status
- Trimmed
- Weight
- 3.49%
- Δ weight
- up 0.29 pts
- Value
- ₹193 Cr
- Δ value
- up ₹11.5 Cr
- Status
- Added
- Weight
- 3.42%
- Δ weight
- down 0.21 pts
- Value
- ₹189 Cr
- Δ value
- down ₹17 Cr
- Status
- Trimmed
- Weight
- 3.31%
- Δ weight
- down 0.15 pts
- Value
- ₹184 Cr
- Δ value
- down ₹13.3 Cr
- Status
- Trimmed
- Weight
- 3.22%
- Δ weight
- up 0.23 pts
- Value
- ₹178 Cr
- Δ value
- up ₹8.3 Cr
- Status
- Added
- Weight
- 3.09%
- Δ weight
- down 0.02 pts
- Value
- ₹171 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 3.08%
- Δ weight
- down 0.01 pts
- Value
- ₹171 Cr
- Δ value
- down ₹5.3 Cr
- Status
- Trimmed
- Weight
- 3.08%
- Δ weight
- up 0.02 pts
- Value
- ₹171 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 2.70%
- Δ weight
- up 0.15 pts
- Value
- ₹150 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 2.10%
- Δ weight
- up 0.05 pts
- Value
- ₹116 Cr
- Δ value
- down ₹29 L
- Status
- Held
- Weight
- 2.08%
- Δ weight
- up 0.09 pts
- Value
- ₹115 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 2.04%
- Δ weight
- down 0.05 pts
- Value
- ₹113 Cr
- Δ value
- down ₹6 Cr
- Status
- Trimmed
- Weight
- 1.75%
- Δ weight
- down 0.01 pts
- Value
- ₹97 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 1.05%
- Δ weight
- down 0.04 pts
- Value
- ₹58.3 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 1.04%
- Δ weight
- up 0.08 pts
- Value
- ₹57.6 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 0.86%
- Δ weight
- down 0.13 pts
- Value
- ₹47.8 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 0.85%
- Δ weight
- down 0.09 pts
- Value
- ₹47 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 0.67%
- Δ weight
- up 0.18 pts
- Value
- ₹36.9 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 0.37%
- Δ weight
- down 0.05 pts
- Value
- ₹20.6 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 0.27%
- Δ weight
- up 0.02 pts
- Value
- ₹14.8 Cr
- Δ value
- up ₹51 L
- Status
- Added
- Weight
- 0.19%
- Δ weight
- down 0.02 pts
- Value
- ₹10.4 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
What changed, Sep 2023 to Oct 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹35 Cr (+0.73% pts)
- Vijaya Diagnostic Centre Limitedup ₹11.5 Cr (+0.29% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹9 Cr (+0.18% pts)
- Sanofi India Limitedup ₹8.3 Cr (+0.23% pts)
- MedPlus Health Services Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2023, the weight rose most in Healthcare Services (+0.7 pts) and Retailing (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts).
- Healthcare Services16.3% → 17.0%+0.7 pts
- Retailing4.3% → 4.6%+0.2 pts
- Pharmaceuticals & Biotechnology78.0% → 77.2%−0.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2020 | Oct 2022 | Apr 2023 | Jul 2023 | Sep 2023 | Oct 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.8% | 80.1% | 77.7% | 77.3% | 78.0% | 77.2% |
| Healthcare Services | 21.9% | 18.1% | 18.5% | 17.8% | 16.3% | 17.0% |
| Retailing | — | — | 2.1% | 3.5% | 4.3% | 4.6% |
| Pharmaceuticals | 2.3% | 1.4% | 1.4% | 1.1% | 1.1% | 1.1% |
| Healthcare Equipment & Supplies | — | 0.4% | 0.3% | 0.3% | 0.2% | 0.2% |
Allocation in Oct 2023change vs Sep 2023
- Pharmaceuticals & Biotechnology (20)77.2%▼ 0.8 pts
- Healthcare Services (7)17.0%▲ 0.7 pts
- Retailing (1)4.6%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2023
3.9%
unchanged vs Sep 2023
- Cash alone
- 3.9%
- cash and net receivables
- A year earlier
- 2.1%
- Oct 2022 · now ▲ 1.8 pts
- Last 12 months
- 0.4% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.